Advanced in Astrocytoma

Maryline Barrie

264 Rue Saint Pierre, 
Marseille, FR 
Advanced in Astrocytoma
264 Rue Saint Pierre, 
Marseille, FR 
OverviewLocationsClinical Research

Overview

Maryline Barrie practices in Marseille, France. Ms. Barrie is rated as an Advanced expert by MediFind in the treatment of Astrocytoma. Her top areas of expertise are Glioma, Gliomatosis Cerebri, Glioblastoma, and Astrocytoma.

Her clinical research consists of co-authoring 29 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 9 articles in the study of Astrocytoma.

Gender
Female

Locations

264 Rue Saint Pierre, Marseille, 13005, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Study of the Efficacy and Safety of Perampanel in Combination in Glioma-refractory Epilepsy
Study of the Efficacy and Safety of Perampanel in Combination in Glioma-refractory Epilepsy
Enrollment Status: Withdrawn
Publish Date: June 27, 2022
Intervention Type: Drug
Study Phase: Not Applicable
An International, Randomized, Open-label Phase I/II Study of Vismodegib in Combination With Temozolomide Versus Temozolomide Alone in Adult Patients With Recurrent or Refractory Medulloblastomas Presenting an Activation of the Sonic Hedgehog (SHH) Pathway
An International, Randomized, Open-label Phase I/II Study of Vismodegib in Combination With Temozolomide Versus Temozolomide Alone in Adult Patients With Recurrent or Refractory Medulloblastomas Presenting an Activation of the Sonic Hedgehog (SHH) Pathway
Enrollment Status: Terminated
Publish Date: May 21, 2019
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
View 1 Less Clinical Trial

29 Total Publications

Autonomy duration in patients with biopsy-only unresectable IDH wild-type glioblastomas.
Autonomy duration in patients with biopsy-only unresectable IDH wild-type glioblastomas.
Journal: Journal of neuro-oncology
Published: August 26, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Barrie's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile